AXGN · Insider Trading
Axogen, Inc. Common Stock
Every open-market purchase and sale reported by AXGN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Joseph A. Tyndall | Director | Sell | −3,500 | −$173.94K |
| 2026-08-12 | Marc A Began | EVP & General Counsel | MIXED | — | −$2.64M |
| 2026-08-12 | Amy McBride Wendell | Director | MIXED | — | −$448.30K |
| 2026-08-11 | Kathy Johnson Weiler | Director | Sell | −14,150 | −$640.97K |
| 2026-06-26 | Kathy Johnson Weiler | Director | A | +4,392 deriv. | — |
| 2026-06-26 | John Johnson | Director | A | +4,392 deriv. | — |
| 2026-06-26 | Alan M Levine | Director | A | +4,392 deriv. | — |
| 2026-06-26 | Amy McBride Wendell | Director | A | +4,392 deriv. | — |
| 2026-06-26 | Joseph A. Tyndall | Director | A | +4,392 deriv. | — |
| 2026-06-26 | William P. Mr. Burke | Director | A | +4,392 deriv. | — |
| 2026-06-26 | Paul Thomas | Director | A | +5,579 deriv. | — |
| 2026-06-23 | John Johnson | Director | M | +14,150 | — |
| 2026-06-23 | Joseph A. Tyndall | Director | M | +14,150 | — |
| 2026-06-23 | Paul Thomas | Director | M | +18,867 | — |
| 2026-06-23 | William P. Mr. Burke | Director | M | +14,150 | — |
| 2026-06-23 | Alan M Levine | Director | M | +14,150 | — |
| 2026-06-23 | Kathy Johnson Weiler | Director | M | +14,150 | — |
| 2026-06-23 | Amy McBride Wendell | Director | M | +14,150 | — |
| 2026-05-12 | Amy McBride Wendell | Director | MIXED | — | −$45.70K |
| 2026-05-08 | Jens Kemp | Chief Marketing Officer | Sell | −4,000 | −$173.76K |
| 2026-05-08 | Doris Quackenbush | Sales VP | Sell | −3,878 | −$168.72K |
| 2026-05-08 | John Johnson | Director | MIXED | — | −$400.18K |
| 2026-05-08 | Kathy Johnson Weiler | Director | MIXED | — | −$607.03K |
| 2026-05-08 | Lindsey Marie Hartley | CFO | MIXED | +4,412 | −$893 |
| 2026-03-18 | Erick Wayne DeVinney | Chief Innovation Officer | MIXED | +9,847 | −$265.71K |
| 2026-03-18 | Lindsey Marie Hartley | CFO | MIXED | +5,458 | −$116.32K |
| 2026-03-02 | Erick Wayne DeVinney | Chief Innovation Officer | MIXED | +11,802 | −$687.00K |
| 2026-03-02 | Jens Kemp | Chief Marketing Officer | MIXED | +32,304 | −$582.19K |
| 2026-03-02 | Marc A Began | EVP & General Counsel | MIXED | +31,850 | −$414.91K |
| 2026-02-27 | Michael D Dale | Chief Executive Officer | A | +98,000 deriv. | — |
| 2026-02-27 | Lindsey Marie Hartley | CFO | MIXED | +10,823 | −$211.50K |
| 2026-02-24 | Lindsey Marie Hartley | CFO | MIXED | +10,796 | −$237.19K |
| 2025-12-17 | Amy McBride Wendell | Director | MIXED | — | −$978.50K |
| 2025-12-17 | Lindsey Marie Hartley | CFO | MIXED | — | −$319.80K |
| 2025-12-17 | Kathy Johnson Weiler | Director | MIXED | −6,580 | −$1.10M |
| 2025-12-12 | Michael D Dale | Chief Executive Officer | Sell | −25,000 | −$750.00K |
| 2025-12-12 | Marc A Began | EVP & General Counsel | Sell | −13,222 | −$396.66K |
| 2025-12-10 | Paul Thomas | Director | Sell | −21,399 | −$633.71K |
| 2025-12-10 | Lindsey Marie Hartley | CFO | MIXED | +10,613 | −$108.60K |
| 2025-12-10 | Jens Kemp | Chief Marketing Officer | Sell | −8,156 | −$254.53K |
| 2025-12-10 | John Johnson | Director | MIXED | −24,943 | −$1.26M |
| 2025-12-10 | Joseph A. Tyndall | Director | MIXED | — | −$558.55K |
| 2025-12-10 | Marc A Began | EVP & General Counsel | Sell | −9,278 | −$289.55K |
| 2025-12-10 | Erick Wayne DeVinney | Chief Innovation Officer | Sell | −19,517 | −$609.09K |
| 2025-12-10 | Michael D Dale | Chief Executive Officer | Sell | −61,463 | −$1.92M |
| 2025-12-05 | Marc A Began | EVP & General Counsel | A | +22,500 | — |
| 2025-12-05 | Michael D Dale | Chief Executive Officer | A | +150,000 | — |
| 2025-12-05 | Jens Kemp | Chief Marketing Officer | A | +22,500 | — |
| 2025-12-05 | Erick Wayne DeVinney | Chief Innovation Officer | A | +40,000 | — |
| 2025-11-13 | William P. Mr. Burke | Director | MIXED | — | −$362.15K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Guido J Neels | Director | 3,457,854 | $129.53M |
| Erick Wayne DeVinney | Chief Innovation Officer | 262,781 | $9.84M |
| Nir Naor | CFO | 260,868 | $9.77M |
| Amy McBride Wendell | Director | 121,329 | $4.54M |
| Doris Quackenbush | Sales VP | 92,416 | $3.46M |
| Jens Kemp | Chief Marketing Officer | 72,451 | $2.71M |
| Michael D Dale | Chief Executive Officer | 63,537 | $2.38M |
| Lindsey Marie Hartley | CFO | 63,234 | $2.37M |
| Alan M Levine | Director | 50,893 | $1.91M |
| Marc A Began | EVP & General Counsel | 50,135 | $1.88M |
| Paul Thomas | Director | 32,395 | $1.21M |
| William P. Mr. Burke | Director | 21,850 | $818.50K |
| John Johnson | Director | 14,150 | $530.06K |
| Joseph A. Tyndall | Director | 10,650 | $398.95K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AXGN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.